Evolving Treatments for Advanced Renal Cell Carcinoma: ASCO 2023 and Beyond - Episode 16

Key Takeaways in the Treatment of Advanced RCC From KCRS 2023

,

Robert Motzer, MD, and Elizabeth Plimack, MD, discuss clinical findings in the treatment of advanced RCC from the recent KCRS 2023 meeting, emphasizing the significance of circulating tumor cells, advances in imaging, and the potential of adjuvant therapies, particularly pembrolizumab.